News for Lantheus Holdings, Inc. (LNTH)

Summary Lantheus Holdings Inc (LNTH), a leading radiopharmaceutical-focused company, announced it will host a conference call and webcast on August 6, 2025, at

BEDFORD, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the ”œCompany”) ( LNTH) today announced that it will host a conference call and

Lantheus Holdings (LNTH) has finalized its acquisition of Life Molecular Imaging, originally announced earlier this year. This acquisition was part of Lantheus'

Summary Lantheus Holdings Inc (LNTH) announced on July 22, 2025, the successful completion of its acquisition of Life Molecular Imaging Ltd, a subsidiary of Lif

Shares of Lantheus Holdings Inc (LNTH) fell 3.19% in mid-day trading on Jul 18. The stock reached an intraday low of $71.20, before recovering slightly to $71

Key Highlights for Investors: Lantheus Holdings (LNTH) experiences an 8% stock decline due to CMS reimbursement decision. Wall Street analysts provide a

The Fly's latest offering, a YouTube stock market update, provides real-time insights for investors. With a focus on strategy enhancement, TipRanks Premium is n

Shares of Lantheus (LNTH) have dropped by 8.7%, losing $7.08 to reach a price of $74.18. This decline in the stock's value comes amid broader market fluctuation

Investors in Lantheus (LNTH) may find themselves unsatisfied following the Centers for Medicare and Medicaid Services' recent decision to uphold the mean unit c

Riley lowered its price target on LNTH from $122 to $109, maintaining a ‘Buy’ rating on June 24, 2025. This reduction follows the company’s profitability pressures despite the top-line growth.

Lantheus Holdings, Inc. (NASDAQ:LNTH) is one of the best stocks for a Growth Stock Portfolio. Riley lowered its price target on LNTH from $122 to $109, maintaining a ‘Buy’ rating on June 24, 2025. This reduction follows the company’s profitability pressures despite the top-line growth. On one hand, the revenue for Q1 2025 rose 0.8% […]

Lantheus Holdings Inc. (NASDAQ:LNTH) is one of the most undervalued US stocks according to analysts. On June 20, Lantheus Holdings announced its participation in the newly launched FIBRE Consortium, which is a collaborative initiative with Pfizer Inc. (NYSE:PFE) and Lumina Pharmaceuticals. The consortium’s primary goal is to revolutionize the treatment of fibrotic diseases by using […]

Lantheus Holdings (LNTH) has received a reaffirmation of its "Buy" rating from analyst Justin Walsh at B. Riley Securities. Despite maintaining the positive rat

Analyst Yuan Zhi from B. Riley has adjusted the price target for Lantheus (LNTH), reducing it from $122 to $109 while maintaining a Buy rating on the stock. Thi

**media[652300]**

BEDFORD, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (”œLantheus”) ( LNTH), the leading radiopharmaceutical-focused company committed

Summary Lantheus Holdings Inc (LNTH), a leading company in the radiopharmaceutical sector, announced that its CEO, Brian Markison, will present at the Goldman S

Lantheus Holdings (LNTH) CEO Brian Markison to present at Goldman Sachs 46th Annual Global Healthcare Conference. The presentation is scheduled for June

Shares of Lantheus Holdings Inc (LNTH) surged 3.10% in mid-day trading on May 27. The stock reached an intraday high of $76.17, before settling at $76.15, u